Artal Group S.A. - LAVA THERAPEUTICS NV ownership

LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 19 filers reported holding LAVA THERAPEUTICS NV in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of LAVA THERAPEUTICS NV
ValueSharesWeighting
Q3 2023$294
-27.6%
200,0000.0%0.01%0.0%
Q2 2023$406
+22.3%
200,0000.0%0.01%
-35.0%
Q1 2023$332
-52.6%
200,0000.0%0.02%
-48.7%
Q4 2022$700
-99.9%
200,0000.0%0.04%0.0%
Q3 2022$914,000
+54.9%
200,0000.0%0.04%
+21.9%
Q2 2022$590,000
-33.0%
200,0000.0%0.03%
-13.5%
Q1 2022$880,000
-20.0%
200,0000.0%0.04%
+23.3%
Q4 2021$1,100,000
-7.1%
200,0000.0%0.03%
+15.4%
Q3 2021$1,184,000
-45.6%
200,0000.0%0.03%
-40.9%
Q2 2021$2,176,000
-28.4%
200,0000.0%0.04%
-18.5%
Q1 2021$3,038,000200,0000.05%
Other shareholders
LAVA THERAPEUTICS NV shareholders Q2 2021
NameSharesValueWeighting ↓
Bruce & Co., Inc. 771,874$1,150,0920.39%
Novo Holdings A/S 2,400,000$3,528,0000.26%
Redmile Group, LLC 2,074,372$3,090,8140.15%
Alpha Wave Global, LP 109,097$162,5550.10%
Artal Group S.A. 200,000$2940.01%
Tower Research Capital LLC (TRC) 11,960$17,5810.00%
OSAIC HOLDINGS, INC. 48$710.00%
PNC FINANCIAL SERVICES GROUP, INC. 65,000$95,5500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 100$1490.00%
View complete list of LAVA THERAPEUTICS NV shareholders